Disease Updates

The country has also discharged its last Ebola patient and entered the 42-day countdown required to declare the outbreak over.

Although Tanzania has not reported any confirmed Ebola cases, the government continues to enhance preparedness measures through its national contingency plans.

The EBO-PEP platform trial, which has been under development since 2024, will evaluate several medicines as post-exposure prophylaxis for people who have had high-risk contact with filoviruses, the virus family that includes Bundibugyo Ebola.

Breast cancer remains the country’s most commonly diagnosed cancer, accounting for 5,822 new cases, or 16.2% of all cancers.

The initiative focused on border communities, refugee camps, and other vulnerable areas where frequent cross-border movement increases the risk of disease transmission.

Unlike previous Ebola epidemics caused by the Zaire strain, the current Bundibugyo outbreak has no licensed vaccine or approved treatment, making research an urgent public health priority.

Japan will channel the support through the International Federation of Red Cross and Red Crescent Societies (IFRC), the World Food Programme (WFP), and the United Nations Children’s Fund (UNICEF).

The funding comes at a critical time, with health officials warning that the outbreak caused by the rare Bundibugyo strain of Ebola could become one of the most severe in history.

The commitment was announced during a High-Level Emergency Meeting convened by H.E. Évariste Ndayishimiye, President of Burundi and Chairperson of the African Union.